z-logo
open-access-imgOpen Access
Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury
Author(s) -
Peter Pickkers,
Ravindra L. Mehta,
Patrick Murray,
Michael Joannidis,
Bruce A. Molitoris,
John A. Kellum,
Mirjam Bachler,
Eric A. J. Hoste,
Oscar Hoiting,
Kenneth Krell,
Marlies Ostermann,
Wim Rozendaal,
Miia Valkonen,
David Brealey,
Albertus Beishuizen,
Ferhat Meziani,
Raghavan Murugan,
Hilde de Geus,
Didier Payen,
Erik van den Berg,
Jacques Arend
Publication year - 2018
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2018.14283
Subject(s) - medicine , acute kidney injury , sepsis , renal function , placebo , creatinine , alkaline phosphatase , clinical endpoint , adverse effect , urology , randomized controlled trial , intensive care unit , kidney , gastroenterology , pathology , enzyme , biochemistry , chemistry , alternative medicine
Sepsis-associated acute kidney injury (AKI) adversely affects long-term kidney outcomes and survival. Administration of the detoxifying enzyme alkaline phosphatase may improve kidney function and survival.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom